Sort
48,018 grants matching “immunotherapy”
Adoptive Cell Transfer Immunotherapy of Cancer
$2,622,375Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Gene therapy of cancer
$2,622,375Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Adhesion Molecules in Transfusion Biology
$2,622,062Denisa D Wagner · Immune Disease Institute, Inc. · P01 · FY2010 · HL
Essential role of the cyclin-G associated kinase (GAK) in diffuse large B-cell lymphoma progression
$2,617,975Jonathan H Schatz · University Of Miami School Of Medicine · R01 · FY2025 · CA
Molecular and Cellular Determinants of Disease Heterogeneity in COPD
$2,615,792Frank C. Sciurba · University Of Pittsburgh At Pittsburgh · P50 · FY2007 · HL
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,612,197Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2016 · CA
Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders
$2,610,373Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders
$2,609,499Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Combination Therapies to Defeat Melanoma Resistance
$2,608,967Antoni Ribas · University Of California Los Angeles · P01 · FY2021 · CA
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study
$2,608,673Reisa A. Sperling · Brigham And Women'S Hospital · R01 · FY2024 · AG
Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer
$2,607,297Kornelia Polyak · Dana-Farber Cancer Inst · P50 · FY2025 · CA
University of Virginia Cancer Center Support Grant
$2,602,707Thomas P Loughran · University Of Virginia · P30 · FY2020 · CA
University of Virginia Cancer Center Support Grant
$2,602,707Thomas P Loughran · University Of Virginia · P30 · FY2021 · CA
University of Virginia Cancer Center Support Grant
$2,602,707Thomas P Loughran · University Of Virginia · P30 · FY2019 · CA
The Center for Tumor-Immune Systems Biology at MSKCC
$2,601,900Christina S Leslie · Sloan-Kettering Inst Can Research · U54 · FY2023 · CA
Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease
$2,599,447Huntington Potter · University Of Colorado Denver · R01 · FY2023 · AG
Diagnosis, Pathophysiology And Molecular Biology of Pheochromocytoma and Paraganglioma
$2,598,882Karel Pacak · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
Role of microbiome in cancer and inflammation
$2,596,550Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Center of Cancer Nanotechnology Excellence at Johns Hopkins
$2,594,165Peter C Searson · Johns Hopkins University · U54 · FY2011 · CA
Depleting S1P to reverse immune exclusion for effective cancer immunotherapy
$2,592,085Everett Stone · University Of Texas At Austin · R01 · FY2025 · CA
Efficacy of a Nicotine Vaccine for Smoking Cessation
$2,588,831Nabi Biopharmaceuticals · R01 · FY2005 · DA
DNA Sequencing and FACS Core Facilities
$2,587,962Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Nanosystems Biology Cancer Center 2
$2,586,441James R. Heath · California Institute Of Technology · U54 · FY2010 · CA
SPORE in Cervical Cancer
$2,585,813T.-C. Wu · Johns Hopkins University · P50 · FY2006 · CA
Case Clinical Trials Unit
$2,582,654Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2022 · AI